Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27% CAGR | Report by S&S Insider [Yahoo! Finance]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
Austin, Dec. 07, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “ The Genotyping Market was valued at USD 17.9 Billion in 2023 and is projected to reach USD 59.31 Billion by 2032, growing at a compound annual growth rate (CAGR) of 14.27% from 2024 to 2032. ” Advancements in Genomics and Biotechnology Propel Genotyping Market Growth The genotyping market is expanding rapidly, fueled by advancements in genomics and biotechnology that deepen our understanding of genetic variations. These breakthroughs have made genotyping a cornerstone for personalized medicine and precision health by linking genetic differences to disease outcomes. As sequencing technologies become more affordable, their adoption has extended beyond healthcare into fields like agriculture and drug discovery. This accessibility addresses pressing challenges, such as the global burden of genetic disorders and chronic diseases, including cancer and diabetes. The increasing prevalence of these conditio
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Macrogen Consortium win tender for National Bio Big Data Project [Yahoo! Finance]Yahoo! Finance
- Macrogen Consortium win tender for National Bio Big Data ProjectPR Newswire
- Ovation.io and Illumina Collaborate to Advance Genomic Data ResearchBusiness Wire
- Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? [Yahoo! Finance]Yahoo! Finance
- MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed [Yahoo! Finance Canada]Yahoo! Finance Canada
ILMN
Earnings
- 11/4/24 - Beat
ILMN
Sec Filings
- 1/2/25 - Form 4
- 12/9/24 - Form 4
- 12/6/24 - Form SC
- ILMN's page on the SEC website